Breast Cancer Clinical Trial
Official title:
Understanding and Preventing Breast Cancer Disparities in Latinas: Screening Mammography and Latinas: A Multilevel Intervention
¡Fortaleza Latina! is a multi-level randomized trial to increase participation in
mammography screening among Latinas who seek care at a community health center in Western
Washington.
In partnership with the partnering community health center, we have obtained lists of women
patients aged 42 to 74 years old who had not had a mammogram in the last two years and
resided within defined radii of the four clinics. Baseline and one year follow-up surveys
will be obtained by in person home interview. Participants are randomized within clinic to
intervention or comparison group. The intervention consist of two motivational interviewing
sessions, one in person in the home, and one telephone follow-up. The study hypothesis is
that a higher proportion of participants in the motivational interviewing arm will obtain a
screening mammogram within the study period than those in the comparison arm.
Breast cancer is the most common cancer among Hispanic women in the United States (US) and
five-year survival from breast cancer is lower in Hispanic than in non-Hispanic White women.
This reduced survival has a number of potential causes, but differential screening rates may
be a partial explanation, since Hispanic women have lower breast cancer screening rates than
non-Hispanic White women. The overall purpose of the study is to develop and evaluate a
culturally-appropriate intervention aimed at increasing screening mammography rates in a
clinic-based sample of predominantly Mexican American women in Western Washington.
The recruitment goal of the Fortaleza Latina study is approximately 500 Latina women aged
40-74 who have had a clinic visit within the past 5 years, but no recent mammogram, from the
four selected Community Health Center clinics. After providing informed consent and
completing a baseline assessment, eligible women are randomly assigned to intervention or
comparison group, within clinic. The individual-level intervention implements motivational
interviewing (MI) in two participant encounters. MI is a direct counseling style, led by a
promotora (lay health advisor), that elicits behavior change by helping participants explore
and resolve ambivalence.
Of the 2194 women contacted by field interviewers, a total of 710 surveys have been
completed; of these, 542 were eligible and have been randomized and enrolled into the
Fortaleza Latina study (279 intervention, 263 usual care).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |